Aten Primaria (2017) 49:2949
If left unchecked, high blood glucose levels damage blood vessels and organs over time, increasing the risk of various other serious health conditions
The evolving paradigm of obesity treatment necessitates reconsideration of intervention timing, specifically for GLP-1 non-responders who show minimal early progress
doi: 10.1007/s13300-024-01635-1
Similar to tirzepatide, retatrutides activation of GLP-1 and GIP receptors promotes insulin secretion, decelerates digestion, and reduces appetite, contributing to notable weight loss [6, 7, 8]
Possible Side Effects Like any medication, GLP-1 drugs can come with side effects